36 | Ribavirin (Virazole)FDA LinkGeneric
01/2023
-
04/2005 |
24 | Antiviral Agents (Antivirals)IBA
01/2019
-
07/2007 |
20 | InterferonsIBA
01/2020
-
12/2009 |
16 | RNA (Ribonucleic Acid)IBA
01/2023
-
01/2002 |
13 | telaprevirIBA
01/2016
-
04/2009 |
11 | daclatasvirIBA
06/2017
-
09/2012 |
10 | N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2016
-
01/2012 |
8 | Protease Inhibitors (Protease Inhibitor)IBA
01/2018
-
02/2014 |
7 | SofosbuvirIBA
01/2023
-
05/2014 |
7 | peginterferon alfa-2a (Pegasys)FDA Link
01/2016
-
10/2006 |
4 | DNA (Deoxyribonucleic Acid)IBA
01/2020
-
06/2010 |
4 | Proteins (Proteins, Gene)FDA Link
01/2017
-
12/2004 |
4 | Ritonavir (Norvir)FDA Link
01/2016
-
01/2015 |
3 | grazoprevirIBA
01/2019
-
01/2017 |
3 | elbasvirIBA
01/2019
-
01/2017 |
3 | SimeprevirIBA
06/2017
-
02/2016 |
3 | NucleosidesIBA
01/2017
-
04/2013 |
3 | NucleotidesIBA
01/2017
-
04/2013 |
3 | paritaprevirIBA
01/2016
-
06/2015 |
3 | ombitasvirIBA
01/2016
-
06/2015 |
3 | asunaprevirIBA
05/2015
-
01/2013 |
3 | Interferon-alpha (Interferon Alfa)IBA
07/2007
-
04/2005 |
2 | velpatasvirIBA
01/2023
-
12/2015 |
2 | Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2021
-
04/2013 |
2 | Biomarkers (Surrogate Marker)IBA
07/2015
-
12/2004 |
2 | 8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA
05/2015
-
02/2014 |
2 | ErythropoietinFDA Link
11/2013
-
09/2013 |
2 | Hepatitis B e AntigensIBA
01/2009
-
05/2007 |
2 | Alanine Transaminase (SGPT)IBA
05/2007
-
01/2002 |
1 | Oral ContraceptivesIBA
01/2019 |
1 | glecaprevir and pibrentasvirIBA
01/2019 |
1 | Ethinyl Estradiol (Estinyl)FDA LinkGeneric
01/2019 |
1 | Illicit Drugs (Recreational Drugs)IBA
09/2018 |
1 | Hemoglobins (Hemoglobin)IBA
01/2017 |
1 | Tenofovir (Viread)FDA Link
10/2016 |
1 | AntigensIBA
04/2016 |
1 | 2'- fluoro- 2'- methyl- 3',5'- diisobutyryldeoxycytidineIBA
01/2016 |
1 | peginterferon lambda-1aIBA
01/2016 |
1 | Hepatitis C AntibodiesIBA
01/2016 |
1 | alisporivirIBA
10/2015 |
1 | N 30IBA
06/2015 |
1 | sofosbuvir drug combination ledipasvirIBA
04/2015 |
1 | danoprevirIBA
01/2015 |
1 | ApolipoproteinsIBA
10/2014 |
1 | beta 2-Glycoprotein I (Apolipoprotein H)IBA
10/2014 |
1 | InterleukinsIBA
02/2014 |
1 | Adrenal Cortex Hormones (Corticosteroids)IBA
02/2012 |
1 | EmollientsIBA
02/2012 |
1 | HCV NS3-4A Protease InhibitorsIBA
01/2012 |
1 | Caffeine (No Doz)FDA LinkGeneric
06/2011 |
1 | adefovir dipivoxil (Hepsera)FDA Link
01/2009 |
1 | RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2009 |
1 | Viral ProteinsIBA
07/2008 |
1 | adefovirIBA
05/2007 |
1 | Lamivudine (Epivir)FDA Link
05/2007 |
1 | Tissue Inhibitor of Metalloproteinase-1IBA
12/2004 |
1 | Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA
12/2004 |
1 | Hyaluronic Acid (Hyaluronan)IBA
12/2004 |
1 | Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
10/2002 |